Skip to main content
. Author manuscript; available in PMC: 2013 Nov 15.
Published in final edited form as: Am J Cardiol. 2012 Aug 9;110(10):1534–1540. doi: 10.1016/j.amjcard.2012.07.014

Table 2.

Clinical characteristics of the participants immediately before, or at the time of the CMRI scan, by gender (numbers are presented as mean ± SD or percentage as appropriate).

Variable Female (n=422) Male (n=467) * p value
Race(%White) 96.7 96.6 0.857
Attained Age (years) 49 ± 7 50 ± 6 0.005
Attained Duration of IDDM (years) 27.8 ± 4.9 27.4 ± 4.8 0.207
Current cigarette smokers (%) 10.7 12.0 0.533
Current drinker (%) 37.2 52.9 < 0.0001
Body Mass Index 27.9 ± 5.3 28.2 ± 4.1 0.043
BMI >= 25 (%) (Overweight) 67.1 75.8 0.004
BMI >= 30 (%) (Obese) 30.3 31.1 0.817
Natural waist-to-hip ratio 0.80 ± 0.07 0.91 ± 0.07 < 0.0001
Weighted systolic blood pressure (mm Hg) 115 ± 8 120 ± 7 < 0.0001
Weighted diastolic blood pressure (mm Hg) 72 ± 5 76 ± 5 < 0.0001
Hypertensive+ (%) 45.0 52.9 0.019
Anti-Hypertensive Medication (%) 36.3 44.5 0.012
Hemoglobin A1c (%)
 Prior to CMRI 8.0 ± 1.3 7.8 ± 1.2 0.063
 Weighted HbA1C 8.0 ± 1.0 7.9 ± 1.0 0.282
Weighted Lipid-HDL Cholesterol (mg/dl) 60 ± 12 50 ± 11 < 0.0001
Weighted Lipid-LDL Cholesterol (mg/dl) 110 ± 20 111 ± 21 0.523
Weighted Lipid-Total Cholesterol (mg/dl) 186 ± 23 178 ± 24 < 0.0001
Weighted Lipid Triglyceride (mg/dl) 78 ± 35 89 ± 45 0.0006
Hypercholesterolemia# (%) 54.3 72.4 < 0.0001
Lipid lowering medication (%) 47.6 67.5 < 0.0001
AER >= 30 mg/24h(%) or ESRD (sustained) 23.7 28.3 0.121
AER >= 300 mg/24h(%) or ESRD (ever) 6.6 11.4 0.015
eGFR < 60 7.8 4.9 0.075
Left Ventricular Mass/BSA (g/m2) 64.0 ± 10.3 76.5 ± 12.2 < 0.0001
Common IMT Year 12 (mm) 0.65 ± 0.10 0.71 ± 0.16 < 0.0001
Any ACE or ARB 49.1 58.7 0.004
Any Beta Blocker 8.1 7.9 0.941
*

p-value based on Chi-Square test for categorical variables and Wilcoxon rank sum test for continuous variables.

+

Hypertension was defined as blood pressure ≥ 140/90 mmHg or use of anti-hypertensive medications.

#

Hypercholesterolemia was defined as low density lipoprotein levels ≥ 130 mg/dl or use of lipid lowering medication